首页> 外文期刊>Advances in Microbiology >Microbiological Assessment and Antimicrobials’ Use in an Infectious Diseases Department in Mali
【24h】

Microbiological Assessment and Antimicrobials’ Use in an Infectious Diseases Department in Mali

机译:微生物评估和抗菌剂在马里传染病部门的用途

获取原文
           

摘要

The use of antimicrobials without microbiological proof is frequent and contributes to the emergence of resistance. The aim was to identify the organisms isolated during laboratory examinations and the type of antimicrobials consumed by patients hospitalized to Infectious Diseases’ Clinic. This is a cross-sectional and analytical study, carried out from January 1 to December 31, 2017 in the Infectious Diseases Department of Point “G” Teaching Hospital in Mali. All biological specimens from patients during the study period were analyzed. In total, 322 patients benefited from microbiological test, with a mean age of 40.9 ± 12.2 years (range 15 and 74 years) with a sex ratio of 0.93. Only 5.6% of patients were HIV negative. In all participants, a total of 658 microbiological specimen were taken, 224 (34.0%) identified at least one pathogen including bacteria in more than a half of the cases (58.5%). On the report of bacteriological analysis, the most frequently identified organisms were Mycobacterium tuberculosis (42.2%) mainly in sputum; Escherichia coli (24.2%) and Klebsiella pneumoniae (7.8%) commonly in urine and Gardnerella vaginalis (7.0%) exclusively in vaginal secretions. Candida albicans (5/8) and Cryptococcus neoformans (3/8) were the most common fungi while Plasmodium falciparum (96.4%) represented the parasite frequently found in blood. From a therapeutic standpoint, 1143 antimicrobials were prescribed to 322 admitted patients, i.e. 3.55 anti-infectives per patient. Antibiotics (excluding tuberculosis drugs), antiparasitics and antifungals represented respectively 46.2%; 18.8% and 15.1% of anti-infectives. Antibiotic therapy was effective in 274 (85.1%) patients and among them, only 76 (27.7%) cases were based on microbiological evidence. Antibiotics are the most widely used antimicrobials in an infectious disease department. Empiric treatments are common but must be minimized by the search for microbiological evidence.
机译:使用没有微生物证明的抗微生物剂频繁且有助于抗性的出现。目的是鉴定实验室检查期间分离的生物以及住院患者消耗的患者消耗的抗菌剂的类型。这是一项横断面和分析研究,从2017年1月1日至2017年12月31日进行的,在马里的“G”教学医院的传染病部门。分析了研究期间来自患者的所有生物标本。总共有322名患者受益于微生物试验,平均年龄为40.9±12.2岁(范围15和74岁),性别比为0.93。只有5.6%的患者是HIV阴性。在所有参与者中,共采取658个微生物标本,224例(34.0%)鉴定了至少一种病例,包括超过一半的病例(58.5%)。在细菌学分析的报告中,最常鉴定的生物是结核分枝杆菌(42.2%)主要是痰; 大肠杆菌(24.2%)和 Klebsiella肺炎(7.8%)通常在尿液中和 Gardnerella阴道(7.0%)仅在阴道分泌物中。 念珠菌(5/8)和肾上腺球菌新族裔(3/8)是最常见的真菌,而第>疟原虫(96.4%)代表血液中经常发现的寄生虫。从治疗角度来看,1143个抗微生物服用322名患者,即。 3.55每位患者的抗感染性。抗生素(不包括结核病药物),抗脂肪酸和抗生素分别代表46.2%; 18.8%和15.1%的抗感染性。抗生素治疗在274例(85.1%)和其中患者中有效,其中仅76例(27.7%)案件基于微生物证据。抗生素是传染病部门使用的最广泛使用的抗菌药物。经验性处理是常见的,但必须通过寻找微生物证据来最小化。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号